Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Previews “Must Attend” Breakout Sessions at 13th Annual BIO World Congress on Industrial Biotechnology

Feb 24 2016
The Biotechnology Innovation Organization (BIO) today announces the “must attend” Breakout Sessions for BIO’s 2016 World Congress on Industrial Biotechnology. The 2016 World Congress on Industrial Biotechnology program will feature 70 sessions in eight 8 tracks over three days. This year’s conference will be held April 17-20 in San Diego, CA at the San Diego Convention Center. 

BIO Applauds Senate GMO Labeling Bill

Feb 19 2016
Legislation eliminates confusion, enhances transparency

BIO President & CEO Jim Greenwood to Testify at Congressional Hearing on Combatting Biological Threats

Feb 11 2016
Former HHS Secretary Donna Shalala will also testify

BIO’s Brent Erickson in Biofuels Digest Top 10 People in the Advanced Bioeconomy for 2016

Feb 11 2016
Biofuels Digest, a top trade publication for the industrial biotech industry, recently published its list of the “Top 100 People in the Advanced Bioeconomy” for 2016. Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization (BIO)’s Industrial and Environmental Section, was number ten.

BIO Opens Nominations for the Third Annual Rosalind Franklin Award

Feb 10 2016
The Rosalind Franklin Award is given annually to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. The Biotechnology Innovation Organization (BIO) will begin accepting nominations for the Award today. The award will be presented and the winner will deliver remarks at the 2016 World Congress on Industrial Biotechnology in San Diego, California, which will be held April 17-20, 2016 at the San Diego Convention Center.  

BIO Applauds Advancement of Senate Innovation Initiative Legislation

Feb 10 2016
The Biotechnology Innovation Organization (BIO) applauds the passage yesterday by the Senate Health Committee of legislative components of the bipartisan Innovation Initiative to accelerate the pace of medical advancement.  

President’s Proposed 2017 Budget Poses Threat to Medical Innovation

Feb 9 2016
Elements of the President’s budget proposal for 2017 directly threaten his Administration’s goal of curing cancer through advances in precision medicine

BIO Premieres New Ad Highlighting the Value of Biomedical Innovation

Feb 8 2016
Ad Launches Campaign Spotlighting Benefits and Value of Medical Breakthroughs

BIO Releases First-Ever Industry Principles on Value of Biopharmaceuticals

Feb 3 2016
Innovative biopharmaceutical industry focused on value, advocating for needed reforms

BIO Applauds House for Passing Legislation to Enhance Small Businesses’ Voice at the SEC

Feb 2 2016
BIO applauds the House of Representatives for approving the SEC Small Business Advocate Act (H.R. 3784) and the Small Business Capital Formation Enhancement Act (H.R. 4168). These bills would enhance the role that small businesses play in the decision-making process at the Securities and Exchange Commission, ensuring that SEC policies support the growth of emerging biotech innovators.